C. Bumma

1.2k total citations
52 papers, 806 citations indexed

About

C. Bumma is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Bumma has authored 52 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 19 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Bumma's work include Cancer Treatment and Pharmacology (14 papers), Lung Cancer Research Studies (10 papers) and Head and Neck Cancer Studies (10 papers). C. Bumma is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Lung Cancer Research Studies (10 papers) and Head and Neck Cancer Studies (10 papers). C. Bumma collaborates with scholars based in Italy, United States and Switzerland. C. Bumma's co-authors include Mario Airoldi, Fulvia Pedani, Sara Marchionatti, Giovanni Succo, Anna Maria Gabriele, P. Gabriele, Riccardo Ragona, G Cortesina, Luigi Cattel and Alessandro Comandone and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

C. Bumma

50 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bumma Italy 16 546 376 187 186 122 52 806
Fulvia Pedani Italy 16 522 1.0× 511 1.4× 230 1.2× 164 0.9× 82 0.7× 42 871
J.M. del Campo Spain 10 373 0.7× 155 0.4× 182 1.0× 217 1.2× 211 1.7× 17 639
Orhan G. Yigitbasi Türkiye 18 323 0.6× 187 0.5× 90 0.5× 286 1.5× 303 2.5× 49 982
Iris Gluck Israel 15 634 1.2× 303 0.8× 369 2.0× 307 1.7× 142 1.2× 26 1.0k
D. Haraf United States 13 431 0.8× 418 1.1× 478 2.6× 325 1.7× 95 0.8× 34 878
Tamara Rordorf Switzerland 15 421 0.8× 175 0.5× 218 1.2× 210 1.1× 88 0.7× 37 678
E. Samantas Greece 13 563 1.0× 358 1.0× 227 1.2× 265 1.4× 230 1.9× 24 934
C Jaulerry France 15 397 0.7× 361 1.0× 557 3.0× 234 1.3× 43 0.4× 37 873
D. Bafaloukos Greece 13 566 1.0× 102 0.3× 42 0.2× 185 1.0× 191 1.6× 37 777
Arnon I. Dreyfuss United States 10 434 0.8× 388 1.0× 398 2.1× 191 1.0× 83 0.7× 15 694

Countries citing papers authored by C. Bumma

Since Specialization
Citations

This map shows the geographic impact of C. Bumma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bumma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bumma more than expected).

Fields of papers citing papers by C. Bumma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bumma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bumma. The network helps show where C. Bumma may publish in the future.

Co-authorship network of co-authors of C. Bumma

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bumma. A scholar is included among the top collaborators of C. Bumma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bumma. C. Bumma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katsaros, D, Irene A. Rigault de la Longrais, Annamaria Ferrero, et al.. (2005). Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma. Annals of Oncology. 16(2). 300–306. 20 indexed citations
2.
Airoldi, Mario, Luigi Cattel, G Cortesina, et al.. (2004). Docetaxel, Carboplatin and Concomitant Radiotherapy for Unresectable Squamous Cell Carcinoma of the Head and Neck. American Journal of Clinical Oncology. 27(2). 155–163. 13 indexed citations
3.
4.
Airoldi, Mario, Luigi Cattel, Sara Marchionatti, et al.. (2003). Docetaxel and Vinorelbine in Recurrent Head and Neck Cancer. American Journal of Clinical Oncology. 26(4). 378–381. 15 indexed citations
5.
Airoldi, Mario, G Cortesina, C. Giordano, Fulvia Pedani, & C. Bumma. (2003). Ifosfamide in the Treatment of Head and Neck Cancer. Oncology. 65(Suppl. 2). 37–43. 16 indexed citations
6.
Airoldi, Mario, G Cortesina, Carlo Giordano, et al.. (2003). Docetaxel and Vinorelbine: An Effective Regimen in Recurrent Squamous Cell Esophageal Carcinoma. Medical Oncology. 20(1). 19–24. 19 indexed citations
7.
Airoldi, Mario, et al.. (2003). Clinical Data and Pharmacokinetics of a Docetaxel-vinorelbine Combination in Anthracycline Resistant/Relapsed Metastatic Breast Cancer. Acta Oncologica. 42(3). 186–194. 11 indexed citations
8.
Bonadonna, Gianni, Milvia Zambetti, C. Bumma, et al.. (2002). Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group. Annals of Oncology. 13(7). 1049–1058. 7 indexed citations
9.
Cattel, Luigi, et al.. (2001). A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions. Il Farmaco. 56(10). 779–784. 7 indexed citations
10.
Airoldi, Mario, Antonella De Stefani, Sara Marchionatti, et al.. (2001). Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio‐chemotherapy. Head & Neck. 23(4). 298–304. 8 indexed citations
11.
Donadio, Michela, Alfredo Berruti, Alberto Bottini, et al.. (2001). Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. Cancer Chemotherapy and Pharmacology. 47(5). 391–396. 8 indexed citations
12.
13.
Airoldi, Mario, Fulvia Pedani, Sara Marchionatti, et al.. (2001). Feasibility and long‐term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma. Head & Neck. 23(9). 799–803. 9 indexed citations
14.
Airoldi, Mario, Fulvia Pedani, Giovanni Succo, et al.. (2001). Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer. 91(3). 541–547. 128 indexed citations
15.
Ceruti, Maurizio, et al.. (1999). Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions. Il Farmaco. 54(11-12). 733–739. 19 indexed citations
16.
Comandone, Alessandro, et al.. (1998). Pharmacokinetics of Ifosfamide Administered According to Three Different Schedules in Metastatic Soft Tissue and Bone Sarcomas. Journal of Chemotherapy. 10(5). 385–393. 13 indexed citations
17.
18.
Fontana, Dario, Oscar Bertetto, G. Fasolis, et al.. (1998). Randomized Comparison of Goserelin Acetate versus Mitomycin C plus Goserelin Acetate in Previously Untreated Prostate Cancer Patients with Bone Metastases. Tumori Journal. 84(1). 39–44. 9 indexed citations
19.
Toma, S., Mario Airoldi, Raffaella Palumbo, P Raffo, & C. Bumma. (1997). Combination of alpha-interferon 2a (α-IFN 2a) and 13-CIS-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN). International Journal of Cancer. 70(4). 491–493. 3 indexed citations
20.
Bretti, S., Alfredo Berruti, G. Gorzegno, et al.. (1996). Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients. Lung Cancer. 14(2-3). 353–360. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fulvia Pedani Breakdown of academic impact, for papers by J.M. del Campo Breakdown of academic impact, for papers by Orhan G. Yigitbasi Breakdown of academic impact, for papers by Iris Gluck Breakdown of academic impact, for papers by D. Haraf Breakdown of academic impact, for papers by Tamara Rordorf Breakdown of academic impact, for papers by E. Samantas Breakdown of academic impact, for papers by C Jaulerry Breakdown of academic impact, for papers by D. Bafaloukos Breakdown of academic impact, for papers by Arnon I. Dreyfuss
Rankless by CCL
2026